🩸 Merging science and sensitivity: Dr Zachary Frosch – touchHAEMATOLOGY Future Leader 2025 As Assistant Professor at Fox Chase Cancer Center, Dr Zachary Frosch brings a thoughtful, patient-centred approach to cancer care—balancing clinical options with individual priorities. In this interview, he shares how: 🔹 Patient preferences shape treatment decisions 🔹 Clinical challenges inspire his research 🔹 Mentorship helped shape his communication style and dual focus on care and science 📖 Read more: https://lnkd.in/esdyUqEa #FutureLeader2025 #OncologyCare #PatientCentredCare #CancerResearch #Haematology #CLL

🩸 Merging science and sensitivity: Dr Zachary Frosch – touchHAEMATOLOGY Future Leader 2025 As Assistant Professor at Fox Chase Cancer Center, Dr Zachary Frosch brings a thoughtful, patient-centred approach to cancer care—balancing clinical options with individual priorities. In this interview, he shares how: 🔹 Patient preferences shape treatment decisions 🔹 Clinical challenges inspire his research 🔹 Mentorship helped shape his communication style and dual focus on care and science 📖 Read more: https://lnkd.in/esdyUqEa #FutureLeader2025 #OncologyCare #PatientCentredCare #CancerResearch #Haematology #CLL

🩸 Merging science and sensitivity: Dr Zachary Frosch – touchHAEMATOLOGY Future Leader 2025 As Assistant Professor at Fox Chase Cancer Center, Dr Zachary Frosch brings a thoughtful, patient-centred approach to cancer care—balancing clinical options with individual priorities. In this interview, he shares how: 🔹 Patient preferences shape treatment decisions 🔹 Clinical challenges inspire his research 🔹 Mentorship helped shape his communication style and dual focus on care and science 📖 Read more: https://lnkd.in/esdyUqEa #FutureLeader2025 #OncologyCare #PatientCentredCare #CancerResearch #Haematology #CLL

🔬 Advancing Cancer Research in Flint, Michigan National Minority Quality Forum has awarded Michigan State University's Flint Community Cancer Consortium a grant to explore a vital cancer study in Flint, MI—a critical step toward addressing health disparities and advancing community-centered research. Learn more: https://lnkd.in/dY2h-qws #CancerResearch #HealthEquity #FlintMichigan #PublicHealth

How can we improve clinical research in the UK? Cancer Research UK commissioned Transforming Evidence to conduct a comprehensive review of the literature and interview clinical leaders from other countries. The resulting report, published today, offers actionable insights and international perspectives to help bridge the gap between policy and practice in UK clinical research. Read the full report: https://lnkd.in/evH96nwS Explore the CRUK summary here: https://lnkd.in/exBdvpVk

Radon is known to cause lung cancer — but new research from Boys Town National Research Hospital suggests it may also affect how children’s brains develop. Read how one Nebraska scientist is uncovering the hidden risks. https://lnkd.in/gYBjAqaR #nebraskaresearch #BoysTownResearch #RadonResearch

Research in the journal Cancer (American Cancer Society Journals) links inflammation to fatigue in women treated for early-stage breast cancer. Managing inflammation through activity, CBT, or mindfulness could help reduce this persistent exhaustion. More in U.S. News & World Report: https://ow.ly/WiEC50XaHhC #BCAM 💗 UCLA Health

Diversity in clinical trials isn’t just a statistic, it’s essential to ensuring research findings are relevant and equitable for every patient. At Mary Bird Perkins Cancer Center, we are committed to rebuilding our clinical trials program from the ground up with diverse enrollment as a core priority. Under the leadership of Victor Lin, MD, PhD, medical director of Clinical Research and Genetics, we are taking concrete steps to expand access and improve representation, supported by a $400,000 grant from the Gilead Foundation. 📖 Read more about our approach and vision for the future in this Association of Cancer Care Centers Buzz feature: 👉 https://bit.ly/4ntebwh #ClinicalTrials #DiversityInResearch #MaryBirdPerkins #OncologyInnovation #CommunityInAction

Postdoctoral fellow Alessandra Riggio, PhD, studies how hormone-dependent breast cancer cells survive treatment and later awaken to cause relapse. In the lab of Dr. Alana Welm, she’s working to uncover how to keep those cells dormant—or eliminate them entirely. Alessandra reminds us that every breakthrough takes collaboration, resilience, and the shared goal of improving the lives of patients and families everywhere.

NIH-supported research has led to major improvements in cancer detection, treatment, and prevention, saving 3.5 million lives since 1991. Today, more than 15 different tumors can be treated by immunotherapy, but hundreds of others could be addressed with this approach. Sustained NIH funding is critical to ensure researchers can continue working toward lifesaving breakthroughs. #FundNIH #MedicalResearchMonth